Agenus | Resultado Líquido





Resultado Líquido Alterar Data
AbbVie USD 1.82B 1.63B 2025-12
Agenus USD -25.27M 20.59M 2025-03
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Celldex Therapeutics USD -67.04M 10.44M 2025-09
CSL USD 497.5M 1.51B 2025-06
Dynavax Technologies USD 18.72M 114.82M 2025-06
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Incyte USD 299.28M 124.89M 2025-12
J&J USD 5.12B 36M 2025-12
Jiangsu Hengrui CNY 1.3B 1.27B 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD 16.82M 53.07M 2025-09
Merck EUR 902M 250M 2025-09
Merck USD 2.96B 2.82B 2025-12
Novartis USD 3.93B 96M 2025-09
Novavax USD -121.3M 283.68M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 19.14M 20.12M 2025-09


Agenus Resultado Líquido - Valores atuais, dados históricos, previsões, estatísticas, gráficos e calendário econômico - Feb 2026.